Calls Now Open
2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs
April 16, 2024
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2024 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for heart disease, autoimmune disorders, cancer, infectious disease, inflammation, and rare diseases using small molecule...
Continue ReadingSeptember 13, 2016
The Lasker Awards, among the most respected prizes in medicine, will go to six researchers who made major discoveries in physiology and virology, and to a scientist who has tirelessly promoted science education, the announced on Tuesday.The awards, honoring basic medical research, clinical research and special achievement... Continue Reading
August 15, 2016
Cleveland – The Trustees of the Burton D. Morgan Foundation in Hudson Ohio have awarded a grant of $200,000 to the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to support the Institute’s Innovation Support Center (ISC) and its mission of mentoring physician-scientists to advance novel... Continue Reading
June 13, 2016
LONDON AND CLEVELAND, OHIO, JUNE 13, 2016: Arix Bioscience Limited (Arix Bioscience), a global healthcare and life science company supporting medical innovation, announced today it has provided development capital to OptiKira, LLC (OptiKira), an early stage company developing drugs to help prevent blindness.Extensive research... Continue Reading
June 06, 2016
When the Lauder family founded the Alzheimer’s Drug Discovery Foundation (ADDF) in 1998, they knew that proprietary boundaries would only limit efforts to develop effective Alzheimer’s drugs. So they resolved to make the ADDF’s knowledge available to everyone working to overcome this devastating disease—and all the... Continue Reading
May 05, 2016
For the past decade, venture philanthropists have been working to propel promising therapies and vaccines into the clinic, with some success.Venture philanthropist Bill Gates looks on as a health worker vaccinates a child in GhanaIn December 2015, Facebook founder Mark Zuckerberg and his wife Priscilla Chan made a stunning... Continue Reading
May 02, 2016
CLEVELAND AND INDIANAPOLIS – May 2, 2016 – BioMotiv, a drug development accelerator associated with the Harrington Project, and Indiana University Research and Technology Corp. announce the formation of a new biotechnology start-up, Allinaire Therapeutics. Allinaire Therapeutics aims to develop novel therapeutics for... Continue Reading
May 01, 2016
- 2016 Gund-Harrington Scholar Continue Reading
May 01, 2016
- 2016 Oxford-Harrington Scholar Continue Reading
April 18, 2016
LONDON, APRIL 18, 2016: - Arix Bioscience Limited (Arix Bioscience), formerly Perceptive Bioscience Investments Limited, a global healthcare and life science company supporting medical innovation, announced today it has agreed to provide up to $25 million capital to BioMotiv LLC, a US-based therapeutic accelerator organization... Continue Reading
April 13, 2016
WILMINGTON, MA, April 13, 2016 – Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development. Through this partnership, Charles River will... Continue Reading